Nanobiotix’s Phase 1 trial in pancreatic cancer safe to proceed (FDA)
another step forward for NBTXR3 activated by radiation therapy
Pharmaceuticals, Biotechnology and Life Sciences
another step forward for NBTXR3 activated by radiation therapy
Rocket Pharmaceuticals has reported a strong balance sheet with $275.9 million in cash, capitalized into 2022.
PinCell has added new members to its management team and the board of directors following a successful seed funding led by Sofinnova Partners
Transgene posts €35.3 million in cash and cash equivalents in Q1 2020, with minor impact from the Covid-19 pandemic seen to-date
DongWha Pharm’s said it is getting ready for second phase of clinical trials of new drug candidate DW2008 to treat COVID-19.
PHILADELPHIA–(BUSINESS WIRE)–Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell…
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…
Spruce Biosciences has announced the appointments of Samir Gharib, MBA, CPA, as Chief Financial Officer (CFO), and Dasharatha Reddy, Ph.D., as Vice President, Pharmaceutical Development and Manufacturing.
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of…